Marie P. Janssen
Maastricht University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Marie P. Janssen.
Biochemical Journal | 2005
Edouard M. Bevers; Marie P. Janssen; Paul Comfurius; Krishnakumar Balasubramanian; Alan J. Schroit; Robert F. A. Zwaal; George M. Willems
The plasma protein beta2GPI (beta2-glycoprotein I) has been proposed to mediate phagocytosis of apoptotic cells and to play a role in the antiphospholipid syndrome. This suggestion is based mainly on the presumption that beta2GPI has an appreciable interaction with PS (phosphatidylserine)-exposing cell membranes. However, quantitative data on the binding of beta2GPI to PS-exposing cells under physiologically relevant conditions are scarce and conflicting. Therefore we evaluated the binding of beta2GPI to PS-expressing blood platelets. Flow cytometry showed that binding of beta2GPI is negligible at physiological ionic strength, in contrast with significant binding occurring at low ionic strength. Binding parameters of beta2GPI and (for comparison) prothrombin were quantified by ellipsometric measurement of protein depletion from the supernatant following incubation with platelets. At low ionic strength (20 mM NaCl, no CaCl2), a dissociation constant (K(d)) of 0.2 microM was found for beta2GPI, with 7.4x10(5) binding sites per platelet. Under physiologically relevant conditions (120 mM NaCl and 3 mM CaCl2), binding of beta2GPI was not detectable (extrapolated K(d)>80 microM). Prothrombin binding (at 3 mM CaCl2) was much less affected by ionic strength: K(d) values of 0.5 and 1.4 muM were observed at 20 and 120 mM NaCl respectively. The low affinity and the presence of many lipid-binding proteins in plasma that can compete with the binding of beta2GPI suggest that only a small fraction (<5%) of the binding sites on PS-exposing blood cells are likely to be occupied by beta2GPI. These findings are discussed in relation to the alleged (patho-)physiological functions of beta2GPI.
Biochemistry | 1998
George M. Willems; Marie P. Janssen; Irene Salemink; Tze-Chein Wun; Theo Lindhout
The interaction of tissue factor pathway inhibitor (TFPI), factor Xa, and TFPI-factor Xa complexes with negatively charged phospholipid membranes composed of 25 mol % phosphatidylserine and 75 mol % phosphatidylcholine was studied by ellipsometry. The binding of TFPI alone was negligible; factor Xa bound with moderate affinity, with a dissociation constant Kd = 42 nM. Formation of the TFPI-factor Xa complex drastically enhanced the affinity for phospholipid membranes, Kd = 5 nM, compared to that of either protein alone. TFPI1-161, a TFPI variant lacking the third Kunitz domain and the positively charged C-terminus did not enhance binding affinity of the factor Xa. Analysis of the kinetics of adsorption and desorption confirmed the equilibrium binding data, although upon longer residence at the lipid membrane the desorption rate of TFPI-factor Xa complexes became slower, indicating an increase in affinity with longer residence of the TFPI-factor Xa complexes at the membrane. In contrast, binding of TFPI-factor Xa complexes in the presence of an excess factor Xa was transient; maximal binding is followed by a slow desorption of the complex. Immunoblot analysis revealed that this desorption was accompanied with cleavage of TFPI by membrane-bound factor Xa. Collectively, our results show that phosphatidylserine containing membranes will accumulate tightly bound TFPI-factor Xa complexes, and that uncomplexed, phospholipid-bound, factor Xa, will cause limited proteolysis of TFPI accompanied by simultaneous release of these complexes from the phospholipid membrane.
Biochemistry | 1996
George M. Willems; Marie P. Janssen; Maurice M. A. L. Pelsers; Paul Comfurius; Monica Galli; Robert F. A. Zwaal; Edouard M. Bevers
Biochemistry | 2000
George M. Willems; Marie P. Janssen; Paul Comfurius; Monica Galli; Robert F. A. Zwaal; Edouard M. Bevers
Biochemistry | 2001
Kristin M. Seré; Marie P. Janssen; George M. Willems; Guido Tans; Jan Rosing; Tilman M. Hackeng
Thrombosis and Haemostasis | 2000
Edouard M. Bevers; Marie P. Janssen; George M. Willems; Robert F. A. Zwaal
Biochemistry | 1992
José W. P. Govers-Riemslag; Marie P. Janssen; Robert F. A. Zwaal; Jan Rosing
Archive | 1987
Peter A. Cuypers; George M. Willems; J.M.M. Kop; Jan W. Corsel; Marie P. Janssen; Wim Th. Hermens
Biochemistry | 2002
George M. Willems; Marie P. Janssen; Paul Comfurius; Monica Galli; Robert F. A. Zwaal; Edouard M. Bevers
Biochemical Journal | 1995
J Spaargaren; P L A Giesen; Marie P. Janssen; Johannes Jacobus Voorberg; George M. Willems; J A Van Mourik